Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    musculoskeletal

    Mixed connective tissue disease

    Also known as: MCTD, Sharp syndrome, Mixed connective tissue overlap syndrome

    Mixed connective tissue disease (MCTD) is a systemic autoimmune overlap disorder integrating features of systemic lupus erythematosus, systemic sclerosis, and inflammatory myopathy, commonly associated with anti-U1-RNP antibodies. Clinical manifestations include Raynaud’s phenomenon, swollen fingers, synovitis, and muscle symptoms, which may coexist with serious visceral involvement requiring rheumatology-led assessment and monitoring. Traditional Chinese Medicine (TCM) is utilised solely as an adjunct for supportive symptom care; it does not substitute for immunosuppressive therapy or organ-protective interventions. Current literature provides no direct evidence that acupuncture or herbal medicine benefits MCTD; a small, short-term rheumatoid arthritis moxibustion trial cannot establish efficacy or prevention of structural damage in MCTD. Pattern descriptions represent traditional clinical frameworks, not validated biomedical diagnoses or treatment protocols.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Maintain optimal thermal regulation and avoid abrupt cold exposure; avoid the application of intense heat directly to anaesthetic or paraesthetic digits.
    • •Modulate daily activity with scheduled rest periods and adhere to a prescribed physiotherapy regimen; avoid exercising through exacerbations of muscular weakness or arthralgia.
    • •Cessation of smoking is mandatory; patients should consult a medical practitioner for cessation support and maintain a clinical log of Raynaud’s episodes, documenting persistent integumentary discolouration or cutaneous ulceration.
    • •Maintain regular nutritional and sleep hygiene; ensure attendance at all rheumatological monitoring consultations and maintain an accurate record of all pharmacological agents and supplements.

    Cautions & Contraindications

    See sources
    • •Do not start or continue elective acupuncture or herbal treatment during new visual or spinal neurological symptoms; arrange urgent medical assessment. The cited report illustrates rare NMOSD overlap, not evidence for TCM management.[]
    • •Do not use symptomatic treatment to defer investigation of persistent unexplained lymphadenopathy or systemic symptoms. This precaution is informed by a genetic lymphoma-risk signal, not an established individual prediction rule.[]
    • •Defer needling through unexplained papular eruptions pending medical assessment. The supplied dermatology case illustrates that abnormal autoimmune serology can accompany a different skin disorder; it is not a needling-safety study or proof that such lesions are caused by MCTD.[]

    When to reassess or seek care again

    See sources

    If medically stable, review any adjunctive trial after 2–4 weeks using a 0–10 pain score, morning-stiffness duration, fatigue score, functional task tolerance and frequency of Raynaud’s episodes. Stop or revise care if there is no meaningful patient-reported improvement. Increasing swelling, weakness, digital lesions or loss of function requires medical review without waiting for the scheduled reassessment. Organ surveillance and laboratory monitoring remain rheumatology-led.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Frontiers in immunology · 2025
    2. Frontiers in immunology · 2026
    3. Medicine · 2025
    4. Frontiers in immunology · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.